These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7074572)

  • 41. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables.
    Hendrickson M; Ross J; Eifel PJ; Cox RS; Martinez A; Kempson R
    Gynecol Oncol; 1982 Jun; 13(3):373-92. PubMed ID: 6284595
    [No Abstract]   [Full Text] [Related]  

  • 42. [New features in the 2014 WHO classification of uterine neoplasms].
    Lax SF
    Pathologe; 2016 Nov; 37(6):500-511. PubMed ID: 27738815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microglandular adenocarcinoma of the uterus mimicking microglandular cervical hyperplasia.
    Zamecnik M; Skalova A; Opatrny V
    Ann Diagn Pathol; 2003 Jun; 7(3):180-6. PubMed ID: 12808571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytologic findings in endometrial hyperplasia.
    Kashimura M; Baba S; Shinohara M; Kashimura Y; Saito T; Hachisuga T
    Acta Cytol; 1988; 32(3):335-40. PubMed ID: 3376700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of estrogen-induced hyperplasia to endometrial carcinoma.
    Bhagavan BS; Parmley TH; Rosenshein NB; Jefferys JL; Grisso JA; Stolley PD
    Obstet Gynecol; 1984 Jul; 64(1):12-5. PubMed ID: 6738936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnosis of endometrial cancer by DNA cytophotometry].
    Dietl J; Hedderich J; Sprenger E
    Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):796-9. PubMed ID: 3803873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Differential diagnostic cytologic signs of atypical hyperplasia and cancer of the endometrium].
    Iagubov AS; Agamova KA; Starinskiĭ VV; Gladunova ZD; Tikhomirova EE
    Vopr Onkol; 1989; 35(6):680-4. PubMed ID: 2665313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
    Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pitfalls in the diagnosis of endometrial neoplasia.
    Winkler B; Alvarez S; Richart RM; Crum CP
    Obstet Gynecol; 1984 Aug; 64(2):185-94. PubMed ID: 6377150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative analysis of nuclear distribution pattern differentiating carcinoma from hyperplasia in endometrial cytologic studies.
    Tezuka F; Higashiwai H; Namiki T
    Am J Clin Pathol; 1991 Nov; 96(5):648-53. PubMed ID: 1951187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endometrial carcinoma in women 40 years of age or younger.
    Crissman JD; Azoury RS; Barnes AE; Schellhas HF
    Obstet Gynecol; 1981 Jun; 57(6):699-704. PubMed ID: 7015203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the office endometrial biopsy in the detection of endometrial carcinoma and atypical hyperplasia.
    Greenwood SM; Wright DJ
    Cancer; 1979 Apr; 43(4):1474-8. PubMed ID: 445344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
    McKenney JK; Longacre TA
    Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Histopathology and morphologic prognostic criteria in endometrial cancer].
    Schrodt U
    Zentralbl Gynakol; 1987; 109(7):425-31. PubMed ID: 3617989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atypical polypoid adenomyoma of the uterus: A reappraisal of the clinicopathological and immunohistochemical features.
    Lu B; Yu M; Shi H; Chen Q
    Pathol Res Pract; 2019 Apr; 215(4):766-771. PubMed ID: 30661903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
    Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperplasia and carcinoma of the endometrium.
    Silverberg SG
    Semin Diagn Pathol; 1988 May; 5(2):135-53. PubMed ID: 3041508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endometrial hyperplasia and carcinoma. Diagnostic considerations.
    Norris HJ; Tavassoli FA; Kurman RJ
    Am J Surg Pathol; 1983 Dec; 7(8):839-47. PubMed ID: 6660354
    [No Abstract]   [Full Text] [Related]  

  • 59. Endometrial carcinoma: two diseases?
    Deligdisch L; Holinka CF
    Cancer Detect Prev; 1987; 10(3-4):237-46. PubMed ID: 3568022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Atypical adenomatous hyperplasia of the endometrium in a young woman].
    Aimone V; Dolfin GC; Ghiringhello B; Guercio E; Campagnoli C
    Minerva Ginecol; 1981 Jun; 33(6):627-9. PubMed ID: 7279290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.